Lancet Gastroenterol Hepatol 2(12):890899 Halim MA, Degerblad M, Sundbom M, Karlbom U, Holst JJ, Webb D-L et al (2018) Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans
By enhancing its activity or preventing its inhibition, we might be able to bolster the brain's defenses against radiation-induced oxidative stress and ferroptosis
Adult RDA baseline in grams per day = reference weight in kg x 0.8
Cannabis To understand the interaction, we must look at the biological tug-of-war occurring in the body
People taking GLP-1 supplements are looking at brief, pulsatile signals that may nudge appetite at mealtimes
This review summarizes the discovery of GLP-1 and the development of GLP-1RAs, with a particular focus on their central mechanisms of action